The Latest in RSV Protection for Kids: An Antibody Treatment Called Beyfortus

• 2023

  Log in to bookmark this resource.

  Log in
• Lindsay Rogers

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This article describes a new drug called Beyfortus that helps protect babies and toddlers from RSV, a virus causing serious illness in young children. Approved by the FDA, Beyfortus is given as one shot before the RSV season. It reduces severe infections by 74.5%. Unlike vaccines, it provides short-term protection with antibodies. Previously, only Synagis was available but required multiple shots and was costly. While not stopping all infections, Beyfortus aims to keep kids out of hospitals during vulnerable times. Parents should talk to pediatricians about this option as RSV season approaches soon.


---

Tags

Focus Area: Infectious Disease

Audiences: Families & Children; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Immunization; Immunization, Passive; Infant, Newborn; Pneumonia; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Antibodies, Monoclonal, Humanized

Institutions: Johns Hopkins University

---

More like this

How Serious is Bird Flu? 2025 · Johns Hopkins University How Dangerous is Dengue? 2024 · Johns Hopkins University Polio and the Polio Vaccine 2025 · Johns Hopkins University

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---